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Future perspectives in addressing the global issue of vitamin D deficiency
Abstract
Vitamin D is a fundamentally critical nutrient that the human body requires to function properly. It plays an
important role in musculoskeletal health due to its involvement in the regulation of calcium and
phosphorus. Having a low level of vitamin D in the body may be detrimental for a wide range of health
outcomes, including risk of osteoporotic and stress fractures, risk of CVD and some cancers, and
lowering of the capability of the immune system. Vitamin D is an unusual nutrient; it is not a vitamin, in
the true sense of the word but a pro-hormone. The main source of vitamin D is UV exposure, not dietary
intake. Interestingly, there are two forms of vitamin D, vitamin D2 and vitamin D3, both of which are
metabolised into 25-hydroxyvitamin D (25(OH)D) in the liver, the biomarker of vitamin D status. Vitamin D
deficiency is a global public health problem, especially amongst older people and ethnic minority groups.
The newest publication from the UK Government's Public Health England Department recommends that
vitamin D intake should be 10 μg daily and this recommendation compares well (albeit lower) with other
guidelines such as the Institute of Medicine recommendation of 15 μg for those aged 1–70 years and 20
μg for those 70 years or over. Few countries, however, have a specific vitamin D policy to prevent
deficiency in populations. Finland leads the way, demonstrating impressive results in reducing populationlevel vitamin D deficiency through mandatory food fortification programmes. Collaboration between
academia, government and industry, including countries from varying latitudes, is essential to identify
long-term solutions to the global issue of vitamin D deficiency. This paper provides a narrative review of
the evidence related to the role of vitamin D deficiency in health outcomes, outlines controversies
regarding setting levels of adequacy, identifies the prevalence of vitamin D deficiency across the globe,
and identifies population-level strategies adopted by countries to prevent vitamin D deficiency.
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Vitamin D is a fundamentally critical nutrient that the human body requires to function
properly. It plays an important role in musculoskeletal health due to its involvement in the
regulation of calcium and phosphorus. Having a low level of vitamin D in the body may
be detrimental for a wide range of health outcomes, including risk of osteoporotic and stress
fractures, risk of CVD and some cancers, and lowering of the capability of the immune
system. Vitamin D is an unusual nutrient; it is not a vitamin, in the true sense of the word
but a pro-hormone. The main source of vitamin D is UV exposure, not dietary intake.
Interestingly, there are two forms of vitamin D, vitamin D2 and vitamin D3, both of
which are metabolised into 25-hydroxyvitamin D (25(OH)D) in the liver, the biomarker of
vitamin D status. Vitamin D deﬁciency is a global public health problem, especially amongst
older people and ethnic minority groups. The newest publication from the UK Government’s
Public Health England Department recommends that vitamin D intake should be 10 μg daily
and this recommendation compares well (albeit lower) with other guidelines such as the
Institute of Medicine recommendation of 15 μg for those aged 1–70 years and 20 μg for
those 70 years or over. Few countries, however, have a speciﬁc vitamin D policy to prevent
deﬁciency in populations. Finland leads the way, demonstrating impressive results in reducing
population-level vitamin D deﬁciency through mandatory food fortiﬁcation programmes.
Collaboration between academia, government and industry, including countries from varying
latitudes, is essential to identify long-term solutions to the global issue of vitamin D deﬁciency. This paper provides a narrative review of the evidence related to the role of vitamin
D deﬁciency in health outcomes, outlines controversies regarding setting levels of adequacy,
identiﬁes the prevalence of vitamin D deﬁciency across the globe, and identiﬁes populationlevel strategies adopted by countries to prevent vitamin D deﬁciency.
Vitamin D: Deﬁciency: Global: Future perspectives

Vitamin D is essential for musculoskeletal health,
particularly due to its involvement in the regulation of
calcium and phosphorus(1,2). Vitamin D is a unique
nutrient in that it is not a vitamin, in the true sense of
the word, but actually a pro-hormone, with its main

source being an exposure of skin to UV rays (at 290–
315 nm), not dietary intake(2). Over the past two decades,
there has been mounting scientiﬁc and clinical evidence
that vitamin D deﬁciency, deﬁned as 25-hydroxyvitamin
D (25(OH)D) concentrations below 25 nmol/l, and

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; RCT, randomised controlled trial.
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inadequacy, deﬁned as 25(OH)D concentrations below
50 nmol/l, are a major public health issue across all age
groups and populations, but especially amongst older
people and ethnic minority groups (a group of people
who identify with each other, either on the basis of a presumed common genealogy or ancestry or on similarities
such as common language, history, society, culture or
nation)(3–7).
The two main forms of vitamin D are naturally present in a few foods and in small quantities, with ergocalciferol (vitamin D2) from plant and/or fungal sources,
such as mushrooms and cholecalciferol (D3) from animal
origin foods such as oily ﬁsh, butter, eggs and liver. It is
important to appreciate that the vitamin D content in
these food sources can vary dramatically between countries due to environmental and agricultural factors and
that usual dietary intake of vitamin D-rich foods varies
widely between populations(2). For instance, the vitamin
D content of milk is known to be subjected to seasonal
variations, presenting, as expected, higher content in
summer months in comparison to wintertime. Several
studies have indeed demonstrated a variation in vitamin
D concentration in milk, ranging from 0⋅004 to 0⋅0014
μg/g fat, across not only different breeds of cattle, but
also different locations(8).
Habitual exposure of the skin to UVB radiation in
sunlight (wavelength between 290 and 315 nm) converts
the molecule 7-dehydrocholesterol, naturally present in
the epidermis, into pre-vitamin D(32,9). Pre-vitamin D3
is thermodynamically unstable and is thus quickly metabolised to vitamin D3 through thermal isomerisation.
Vitamin D3 then binds to vitamin-D-binding protein in
the bloodstream and is transported to the liver, along
with vitamin D absorbed from dietary sources (food
and supplements)(2). In the liver, these molecules undergo
a ﬁrst hydroxylation by the cytochrome P450 enzyme
CYP2R1 (25-hydroxylase) to produce the major circulating form, 25(OH)D(2). The molecule 25(OH)D undergoes further hydroxylation in the kidneys, by enzyme
CYP27B1 (1α-hydroxylase), resulting in the active form
of vitamin D (1α,25(OH)2D3), which is the main biological active metabolite(2).
Atmospheric conditions, such as cloud, ozone and
humidity can cause absorption or deﬂection of much of
the UV rays in sunlight before it reaches the earth’s surface(10,11). Since ozone absorbs UVB radiation, holes in
the ozone layer caused by pollution could potentially
enhance vitamin D levels of populations due to an
increase of UVB radiation passing through these holes.
Conversely, air pollution will disperse and absorb UVB
radiation, reducing the availability of UVB rays reaching
the ground, and consequently reducing the production of
vitamin D in the skin.
In the UK, the latest data from the rolling National
Diet and Nutrition Survey 2008/2009–2011/2012 provides evidence of an increased risk of vitamin D deﬁciency in all age/sex groups(12). Year-round, 7⋅5 % of
children aged 1⋅5–3 years and 24⋅4 % of children aged
11–18 years had serum 25(OH)D concentrations below
25 nmol/l(12). In adults, 16⋅9 % of men and 24⋅1 % of
women, aged 65 years and over, had serum 25(OH)D
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concentration below 25 nmol/l, with the prevalence
being higher in the wintertime(12). The recent Scientiﬁc
Advisory Committee on Nutrition report published in
2016, suggests that the mean intake of vitamin D (from
all sources, including supplements) for the general
British population is 2–4 μg/d for ages 1⋅5–64 years and
5 μg/d for adults aged 65 years or over(13).

Why is vitamin D so important?
The biologically active vitamin D metabolite 1α,25(OH)2D3
is involved in bone formation as well as bone maturation(1,2). Along with parathyroid hormone, it regulates
calcium and phosphorus metabolism and enhances the
absorption of calcium in the gut and reabsorption of
ﬁltered calcium in the kidney(1,2). Vitamin D is, therefore,
essential to help maintain muscle function and an optimal status may help reduce the risk of falls and fractures,
particularly in older people. Prolonged and severe vitamin D deﬁciency may lead to rickets in children and
osteomalacia/osteoporosis in adults(1,2).
Although data is still largely observational, recent evidence also suggests that Vitamin D may have an important role in the pathophysiology of conditions as diverse
as inﬂammatory and heart diseases, type I and II diabetes, various types of cancer and multiple sclerosis(3,14,15). However, while the essential role of vitamin
D in the maintenance of calcium homeostasis ad skeletal
health is well recognised, there is still a substantial lack of
robust evidence, with few well-designed randomised controlled trials (RCT) to elucidate the effect of vitamin D
deﬁciency in other non-skeletal related health outcomes.
The costs associated with vitamin D deﬁciency in the
population are staggering, with a recent National
Health Service report estimating that approximately 10
million people in England alone may have low vitamin
D status, with treatment costs for vitamin D deﬁciency
calculated to be over £70 million per year for
England(16).

Controversy: where to set the cut-point for total 25(OH)
D status?
Deﬁning vitamin D deﬁciency
The most common criteria used for determining the optimal serum 25(OH)D concentration for bone health in
adults are the levels that result in (1) suppression of parathyroid hormone secretion; (2) greater bone mineral
density; (3) lower rates of bone loss; and (4) decreased
incidence of fractures and falls(17,18). There is still much
debate and controversy about which levels of circulating
25(OH)D should be considered to deﬁne states of deﬁciency, insufﬁciency and sufﬁciency, and consequently
lack of consensus on a deﬁnition for optimal vitamin
D status. There is, though, general agreement that circulating 25(OH)D concentrations of populations should
not decrease below 25 nmol/l in order to preserve bone
health(18,19).
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The UK Scientiﬁc Advisory Committee on Nutrition
classiﬁes vitamin D deﬁciency as 25(OH)D concentrations below 25 nmol/l(13), the Institute of Medicine in
the US deﬁnes insufﬁciency as 25(OH)D concentrations
below 50 nmol/l(19) and the US Endocrine Society proposes 75 nmol/l(20) as the minimum level required to prevent detrimental effects to health.
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Vitamin D recommendations
Previously in the UK, a reference nutrient intake for vitamin D was set only for population groups deemed to be
at high risk of deﬁciency, assuming that for most people
the amount of vitamin D synthesised in the skin by
exposure to sunlight was sufﬁcient to reach serum
25(OH)D concentrations ≥25 nmol/l throughout the
year(13). However, increasing new evidence proved this
not to be the case and the new publication from the
UK Government’s Public Health England Department
recommends a vitamin D daily intake of 10 μg for the
UK population aged 4 years and over, including individuals from minority ethnic groups with darker skin(13).
The Institute of Medicine and the Endocrine Society in
the US recommendations are much higher than the
UK reference standards, namely an RDA of 15 μg of
vitamin D for individuals aged 1–70 years, increasing
to 20 μg for those older than 70 years(19,20).

Vitamin D status worldwide
Over the past three decades, the increasing prevalence of
inadequate vitamin D status has been reported in different populations worldwide(3,5,21–23). The majority of the
data comes from studies and national surveys in high latitude countries, which is not surprising due to the known
challenges of maintaining adequate vitamin D levels in
these locations, especially during winter.
A systematic review conducted in 2013, of studies published in the previous 10 years in apparently healthy individuals, reported a remarkably high prevalence of low
vitamin D status (in places with available data) in all
age groups, but especially in girls and women from the
Middle East(24). More recently, emerging evidence indicates that low vitamin D concentrations are alarmingly
common, also in low latitude countries, despite the abundance of sunlight(25–27).
In the UK, data from the rolling National Diet and
Nutrition Survey programme of 977 individuals showed
a mean 25(OH)D level of 44⋅8 nmol/l in adults aged
19 years or over (Fig. 1). A recent study applying
Vitamin D Standardization Program protocols to fourteen studies, combined with four previously standardised
studies, from representative European populations,
estimated that 40 and 13 % of 55 844 individuals had
average year-round 25(OH)D concentrations below 50
and 30 nmol/l, respectively. Remarkably, dark-skinned
ethnic groups were estimated to have a substantially
higher prevalence of levels below 30 nM, ranging from
3- up to 71-fold, compared to white individuals(23).

A multinational study conducted in 2004/2005 that
included eighteen countries ranging in latitude from 64°
N to 38°S, with 2606 participants, observed that low
25(OH)D concentrations were common among postmenopausal women with osteoporosis, with 64 % of this
sample having levels below 75 nmol/l. Mean 25(OH)D
concentration was 67 (SE 0⋅75) nmol/l and values ranged
from 15 to 607 nmol/l, with regional mean concentrations lowest in the Middle East (51 nmol/l, SE 1⋅25) and
highest in Latin America (74 nmol/l, SE 1⋅5)(4).
In the US, data from the National Health and
Nutrition Examination Survey population reported a
mean 25(OH)D concentration of 65 nmol/l in individuals
aged 20–59 years and 62⋅5 nmol/l within those 60 years
or over (Fig. 1). The number of individuals with 25
(OH)D concentrations below 75 nmol/l almost doubled
from 1994 to 2004, reaching a ﬁgure of nearly 75 % of
the American population by 2004. Within dark-skinned
populations (Black, Hispanic and Asians), the prevalence
of levels below 75 nmol/l was more than 90 % in this
cohort(28).
A longitudinal cohort study in South Australia (latitude 34°S) with 2413 participants, conducted between
2008 and 2010 (Stage 3 of the Nutrition, Water,
Sanitation and Hygiene Study), observed an overall
mean serum 25(OH)D of 69⋅2 nmol/l with 22⋅7 % of the
population having concentrations below 50 nmol/l
(Fig. 1)(29). Another study in Australia in 126 healthy
free-living adults (aged 18–87 years) reported a prevalence of 10⋅2 and 32⋅3 % of individuals with serum
25(OH)D concentrations below 25 and 50 nmol/l,
respectively, at the end of winter(30). Studies conducted
in several different cities in Brazil found a high prevalence of 25(OH)D concentrations below 50 nmol/l, with
values as high as 57⋅3 % in the city of São Paulo (latitude
23°S) (Fig. 1), 31⋅5 % in Recife (latitude 8°S), 63⋅7 % in
Curitiba (latitude 25°S), with the latter study being conducted in adolescents(25,31,32).

Strategies for improving vitamin D status in the
population
Vitamin D supplementation and/or food fortiﬁcation
have been increasingly discussed worldwide as an effective strategy to tackle low vitamin D levels, particularly
since natural food sources are limited in most countries.
Vitamin D supplementation has been gaining popularity
over recent years, in line with widespread claims of the
preventive or therapeutic effects of vitamin D being
related to a diverse range of health outcomes. Over the
past 15 years, research has been dedicated to determining
the best ways of improving vitamin D status of populations, either through the supplemental intake and/or
food fortiﬁcation, and have debated whether vitamin
D2 or D3 should be the preferred source.
It was previously believed that there were no differences between vitamin D2 (ergocalciferol) and vitamin
D3 (cholecalciferol) in their effectiveness in improving
vitamin D concentrations(33). However, a recent randomised, double-blind, placebo-controlled food-fortiﬁcation
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Fig. 1. Mean 25(OH)D (nmol/l) by country.

trial, conducted in 335 healthy South Asian and
Caucasian European women (20–64 years) living in
Southern England, has demonstrated that vitamin D3
was more effective than vitamin D2 in increasing serum
25(OH)D in the wintertime. This suggests that vitamin
D3 might be the better option to optimise vitamin D status within the general population(33). In the trial, study
participants received either a placebo, juice supplemented with 15 μg vitamin D2, biscuit supplemented with
15 μg vitamin D2, juice supplemented with 15 μg vitamin
D3, or biscuit supplemented with 15 μg vitamin D3 daily
for 12 weeks. Serum 25(OH)D was measured by liquid
chromatography–tandem MS at baseline and at weeks
6 and 12 of the study. The ﬁndings from this relevant
study suggested that both juice and biscuits are viable
products for fortiﬁcation strategies to effectively raise
25(OH)D concentrations.
Regarding strategies to reduce vitamin D deﬁciency at
a population level through mandatory food fortiﬁcation
programmes, Finland has taken the lead by implementing a systematic national fortiﬁcation programme and
has shown this to be an effective approach. A voluntary
food fortiﬁcation policy was introduced in Finland in
2003 advising food manufacturers to add 10 μg/100 g
vitamin D to fat spreads and 0⋅5 μg/100 g to milk products. National reports showed that over a period of 10
years, mean 25(OH)D concentrations increased from
47⋅6 to 65⋅4 nmol/l in adults(34). Furthermore, the prevalence of 25(OH)D concentrations below 30 nmol/l
decreased from 13 to 0⋅6 %. It is worth noting that during
the same survey period, reported supplement use also
increased, from 11 to 41 %(34).
In this sense, another key recent project on vitamin D
is the European Commission-funded ODIN project
(food-based solutions for optimal vitamin D nutrition
and health throughout the life cycle), a cross-disciplinary,
collaborative project, including thirty partners from nineteen countries. This project aimed to develop evidence-

based solutions to prevent low vitamin D status
(25(OH)D) <30 nmol/l) using a food-ﬁrst approach(35).
The ODIN project is the ﬁrst internationally standardised dataset of vitamin D status and included almost
56 000 EU residents(35). A summary overview published
in 2018, reported that across a latitude of regions ranging
from 35 to 69°N, 13 and 40 % had serum 25(OH)D
below 30 and 50 nmol/l, respectively, with the risk of
low vitamin D status higher among ethnic minorities(35).
Within the ODIN project, four dose-response RCT were
conducted in Northern Europe, accompanied by a series
of food production studies, food-based RCT and dietary
modelling experiments. The study collaborators concluded that diverse fortiﬁcation strategies could safely
increase population intakes and prevent low vitamin D
status(35).
A review discussing the impact of urban living high
latitude, urban living and ethnicity on 25(OH)D status,
published in 2019, proposes a further discussion on the
key role of a multidisciplinary approach on tackling vitamin D deﬁciency globally(36). This multidisciplinary
approach would bring together and apply knowledge
from dietitians, nutritionists, endocrinologists, psychologists, social scientists, photobiologists, biochemists, engineers, town planners etc. This is crucial to be able to
consider all the aspects involved in vitamin D status of
populations, with particular relevance for ethnic minority
groups(36).
Vitamin D supplementation RCT have consistently
demonstrated the dependence of the response to vitamin
D supplements on initial vitamin D concentrations,
although this factor has not been considered in most
studies conducted in the past(37,38). This is an important
point to be considered when discussing the beneﬁts of
vitamin D supplements, as it might explain the various
negative results from vitamin D supplementation studies
that have investigated its effect on the incidence and risk
of falls and/or fractures. For instance, a recent review
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that investigated the proportion of RCT that studied
vitamin D deﬁcient populations found that 70 % of
RCT included participants with baseline 25(OH)D over
40 nmol/l and of the twenty-ﬁve large RCT (completed
or ongoing), only one investigated a vitamin D deﬁcient
population, while three focused on vitamin D insufﬁcient
populations. Individuals that are vitamin D sufﬁcient are
considered unlikely to beneﬁt from supplementation and
could even potentially mask the beneﬁcial effect to those
with deﬁcient or insufﬁcient levels(39).
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Conclusions
This narrative review has demonstrated that vitamin
D inadequacy is a global public health issue and that
whilst populations at higher latitudes are at greater risk
of deﬁciency, particularly during winter, the concern is
now extended to a global level. Targeting intervention
strategies speciﬁc to each population, country and the
ambient setting is important if beneﬁts are to be
optimised. Studies speciﬁcally designed to investigate
the effect of, and requirements for, vitamin D supplements in each country or ethnic group are urgently
required to contribute to an improved deﬁnition of
vitamin D deﬁciency and more speciﬁc and efﬁcient
recommendations.
Recommendations for either supplementation or food
fortiﬁcation need to consider the availability of each vitamin D source (dietary intake, either from food or supplements, and endogenous production from sunlight
exposure), individual characteristics and lifestyle aspects.
Moreover, there are key considerations to be taken into
account for the proposal of supplementation and fortiﬁcation programmes. Firstly, identiﬁcation of the optimum level of blood concentrations for optimal vitamin
D status and recommended daily intake remains controversial, both of which are the bases for determining supplementation or fortiﬁcation strategies, particularly for
programmes implemented at population levels.
Moreover, such programmes will also need to be tailored
to incorporate culturally and geographically appropriate
choices of vehicles for fortiﬁcation, consider the bioavailability of the fortiﬁcant and consider current intake levels
for each country and/or ethnic group targeted.
Inter-individual variability in vitamin D status could
be reasonably explained by differences in the metabolism
of vitamin D. The VDR gene plays an important role in
Vitamin D metabolism and polymorphisms in this gene
can potentially affect Vitamin D gene expression, meaning that genetic variation could explain the considerable
differences in vitamin D levels among population independently of latitude and sunlight exposure(40).
Moreover, some research suggests that some polymorphisms in GC and CYP2R1 genes (involved in vitamin
D metabolism) are associated with 25(OH)D concentrations(40,41). Therefore further research, with robust data
from clinical trials, investigating genetic factors inﬂuencing vitamin D concentrations could be key in better
understanding how to tackle vitamin D deﬁciency in different populations.

In the near future, climate changes are expected to affect
food production and the interactions between environment, agricultural systems and livestock will have a critical
impact on future diets and health outcomes. However, the
extent and pathways, and potential consequences, are still
mainly unclear. Future research will need to consider an
approach with an interdisciplinary tactic, linking multiple
interactions between environmental changes, agricultural
productivity and livestock systems, with a speciﬁc focus
on vitamin D availability through both food intake and
photochemical production in the skin.
Additional research is still required to understand interindividual variability in the metabolism of vitamin D and
differences in response to supplementation, which may be
due to genetic polymorphisms. Environmental, cultural
and individual factors that inﬂuence vitamin D status,
including during supplementation, need to be better elucidated. Such factors include adiposity, season, cultural and
clothing habits, skin pigmentation, sun exposure and dietary habits also required further investigation to determine
what extent each factor affects vitamin D status.
Regarding supplementation strategies, particular issues
include accessibility to vitamin D supplements and compliance/reluctance with supplement intake.
Most importantly, there is an urgent need for studies
that appropriately investigate the response to supplementation or fortiﬁcation considering initial concentrations of
25(OH)D to interpret the effect of changes between baseline and post-supplementation on the studied outcomes.
Collaborative efforts between academia, government
and industry, including countries from several different
latitudes, are required to implement effective long-term
solutions to this global issue of vitamin D deﬁciency.
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